Notice of Filing of Securities Fraud Class Action against Aeterna Zentaris Inc. by Abraham, Fruchter & Twersky, LLP
November 17 2014 - 10:33AM
Business Wire
Abraham, Fruchter & Twersky, LLP has filed a securities
fraud class action against Aeterna Zentaris Inc. (“Aeterna
Zentaris” or the “Company”) (NASDAQ:AEZS) and certain of its senior
executives in the United States District Court for the District of
New Jersey (the “Court”).
The case alleges that the defendants made materially false or
misleading statements with respect to the safety and efficacy of
the Company’s drug Macrilen™. A November 6, 2014, press release by
the Company brought these facts to light by announcing that the FDA
had issued a Complete Response Letter refusing to approve the
Company’s New Drug Application because of “the lack of complete and
verifiable source data for determining whether patients were
accurately diagnosed with AGHD.”
The lawsuit is brought on behalf of a class (the “Class”) of
investors who purchased shares of Aeterna Zentaris between and
including June 26, 2012 and November 5, 2014 (the “Class Period”).
If you are a member of the Class and wish to serve as a lead
plaintiff, then you must move the Court no later than January 12,
2015. You are, however, under no obligation to move for appointment
as lead plaintiff.
If you would like to discuss this investigation, or if you have
any questions concerning your rights as a potential lead plaintiff,
you may contact: Jeffrey S. Abraham or Philip T. Taylor of Abraham,
Fruchter & Twersky, LLP toll free at (800) 440-8986, or via
e-mail at jabraham@aftlaw.com or ptaylor@aftlaw.com.
Abraham, Fruchter & Twersky, LLP, which is based in New York
and has an office in California, has extensive experience in
shareholder and securities class action cases, and the firm has
been ranked among the leading class action law firms in terms of
recoveries achieved by a survey of class action law firms conducted
by Institutional Shareholder Services.
Attorney Advertising. Prior Results Do Not Guarantee A Similar
Outcome.
Abraham, Fruchter & Twersky, LLPJeffrey S. AbrahamPhilip T.
Taylor800-440-8986
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Apr 2023 to Apr 2024